Our Approach

Three principles: produce at the lowest cost, process into the highest-value product, and retain ownership all the way to the distributor.

Frontier Botanics operates across the full medicinal cannabis value chain: cultivation, processing, and distribution. Our model is built on three principles.

Produce at Africa’s Lowest Cost

Our secured Lesotho site combines outdoor cultivation for volume with indoor Sea of Green techniques for premium, year-round production. GACP certification ensures every gram meets EU pharmaceutical standards.

Process Into Premium Products

Dried flower is the commodity. Rosin and pharmaceutical extracts are the premium products. Solventless rosin commands multiples of dried flower pricing, with a cleaner regulatory profile and growing clinical demand. We are building our model around the highest-value product formats.

Retain Ownership, Sell Direct

Rather than selling raw flower to a contract manufacturer, we retain product ownership through toll processing and sell directly to European distributors at pharmaceutical wholesale prices. This single strategic shift approximately doubles per-unit revenue and is the biggest value lever in our business.

Grow at the lowest cost. Process into the highest-value product. Retain ownership all the way to the distributor. That’s the Frontier Botanics model.

FAQs

Frequently asked questions

Everything you need to know about Frontier Botanics, our operations, and the investment opportunity. Still have questions? Our team is happy to walk you through the detail.

Get In Touch

Is medical cannabis legal in the UK?

Yes. Medical cannabis has been legal in the UK since November 2018 following changes introduced after high-profile cases like that of Alfie Dingley. However, access is tightly regulated and prescriptions are typically issued by specialist doctors. Frontier Botanics operates fully within UK and international legal frameworks to ensure compliance at every stage of production and distribution.

Why is cultivation based in Lesotho?

Lesotho was the first African nation to legalise medical cannabis cultivation and export, offering a stable regulatory environment, favourable climate, and cost-efficient production conditions. This allows Frontier Botanics to produce high-quality, pharmaceutical-grade cannabis at scale while maintaining competitive pricing for international markets.

What makes Frontier Botanics different from other medical cannabis companies?

Frontier Botanics focuses on vertically integrated operations—from cultivation in Lesotho to distribution in the UK—ensuring full control over quality, compliance, and supply chain efficiency. The company combines pharmaceutical standards with scalable infrastructure, positioning itself to meet growing demand in regulated global markets.

What is the current investment opportunity?

Frontier Botanics is currently raising capital to expand cultivation capacity, enhance processing facilities, and secure additional distribution partnerships. The funding round is designed to accelerate growth, increase production output, and strengthen the company’s position within the rapidly expanding global medical cannabis market.

What is the market potential for medical cannabis?

The global medical cannabis market is projected to grow significantly over the coming decade, driven by increasing legalisation, patient demand, and clinical research. Countries across Europe—including the UK—are gradually expanding access, creating a strong long-term growth opportunity for early-stage, compliant operators like Frontier Botanics.

Invest With Us

Ready to explore the opportunity?

Request the investor information pack or speak directly with the team. Available to eligible High Net Worth and Sophisticated Investors.

Request Information +44 (0) 203 996 1741